Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Analysis of Investments

Microsoft Excel

Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities

Abiomed Inc., adjustment to net income

US$ in thousands

Microsoft Excel
12 months ended: Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net income (as reported) 136,505 225,525 203,009 259,016 112,170 52,116
Add: Net unrealized gains (losses) on marketable securities, net of tax (8,092) (303) 1,333 946 (460) (211)
Net income (adjusted) 128,413 225,222 204,342 259,962 111,710 51,905

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)

Abiomed Inc., adjusted profitability ratios

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net Profit Margin
Reported net profit margin 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted net profit margin 12.45% 26.57% 24.30% 33.79% 18.81% 11.66%
Return on Equity (ROE)
Reported ROE 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted ROE 8.54% 16.94% 19.18% 27.75% 16.20% 11.48%
Return on Assets (ROA)
Reported ROA 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted ROA 7.67% 15.07% 16.80% 24.66% 14.21% 9.43%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Abiomed Inc. adjusted net profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.
Adjusted ROE A profitability ratio calculated as adjusted net income divided by shareholders’ equity. Abiomed Inc. adjusted ROE deteriorated from 2020 to 2021 and from 2021 to 2022.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by total assets. Abiomed Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.

Abiomed Inc., Profitability Ratios: Reported vs. Adjusted

Adjusted Net Profit Margin

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Profitability Ratio
Net profit margin1 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income 128,413 225,222 204,342 259,962 111,710 51,905
Revenue 1,031,753 847,522 840,883 769,432 593,749 445,304
Profitability Ratio
Adjusted net profit margin2 12.45% 26.57% 24.30% 33.79% 18.81% 11.66%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 Net profit margin = 100 × Net income ÷ Revenue
= 100 × 136,505 ÷ 1,031,753 = 13.23%

2 Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × 128,413 ÷ 1,031,753 = 12.45%

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Abiomed Inc. adjusted net profit margin ratio improved from 2020 to 2021 but then deteriorated significantly from 2021 to 2022.

Adjusted Return on Equity (ROE)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Profitability Ratio
ROE1 9.08% 16.96% 19.05% 27.65% 16.27% 11.53%
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income 128,413 225,222 204,342 259,962 111,710 51,905
Stockholders’ equity 1,503,326 1,329,675 1,065,466 936,890 689,524 452,071
Profitability Ratio
Adjusted ROE2 8.54% 16.94% 19.18% 27.75% 16.20% 11.48%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × 136,505 ÷ 1,503,326 = 9.08%

2 Adjusted ROE = 100 × Adjusted net income ÷ Stockholders’ equity
= 100 × 128,413 ÷ 1,503,326 = 8.54%

Profitability ratio Description The company
Adjusted ROE A profitability ratio calculated as adjusted net income divided by shareholders’ equity. Abiomed Inc. adjusted ROE deteriorated from 2020 to 2021 and from 2021 to 2022.

Adjusted Return on Assets (ROA)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income 136,505 225,525 203,009 259,016 112,170 52,116
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Profitability Ratio
ROA1 8.16% 15.09% 16.69% 24.57% 14.26% 9.47%
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income 128,413 225,222 204,342 259,962 111,710 51,905
Total assets 1,673,393 1,494,359 1,216,462 1,054,346 786,375 550,414
Profitability Ratio
Adjusted ROA2 7.67% 15.07% 16.80% 24.66% 14.21% 9.43%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × 136,505 ÷ 1,673,393 = 8.16%

2 Adjusted ROA = 100 × Adjusted net income ÷ Total assets
= 100 × 128,413 ÷ 1,673,393 = 7.67%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by total assets. Abiomed Inc. adjusted ROA deteriorated from 2020 to 2021 and from 2021 to 2022.